pcos and glp-1 medications Superior metabolic improvement of polycystic ovary syndrome traits after GLP1-based multi-agonist therapy GLP-1 medications emerging as PCOS

Weeks 5-8: 4mg/week First therapeutic dose

doi: 10.3389/fimmu.2025.1610368 Received 11 April 2025 Accepted 26 June 2025 Published 15 July 2025 Volume 16 - 2025 Edited by Li-Tung Huang, Kaohsiung Chang Gung Memorial Hospital, Taiwan Reviewed by Beata Kasztelan-Szczerbinska, Medical University of Lublin, Poland Edit Posta, University of Debrecen, Hungary Updates Copyright 2025 Migliorisi, Gabbiadini, Dal Buono, Ferraris, Privitera, Petronio, Bertoli, Bezzio and Armuzzi

July 2, 2024

This produces a somewhat more conservative estimate of Medicare Advantage enrollees who could be eligible for the Medicare GLP-1 Bridge